Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal progesterone plus pessary versus vaginal progesterone alone for prevention of preterm delivery in twin pregnancy
IRCT20151207025420N2Phase 4Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of progesterone in preterm birth (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoint: Gestational age at delivery. Started Jul 2024; status: completed.
02
Drugs
progesterone
03
Conditions
preterm birth
Beyond the preview
Go deeper on IRCT20151207025420N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151207025420N2.